Lilly Zyprexa IM Launch Planned For 2001; 2Q Sales Top $550 Mil.

Lilly hopes to introduce an intramuscular formulation of the antipsychotic Zyprexa by mid-2001.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet